Increased susceptibility of striatal mitochondria to calcium-induced permeability transition

scientific article (publication date: 15 June 2003)

Increased susceptibility of striatal mitochondria to calcium-induced permeability transition is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1523/JNEUROSCI.23-12-04858.2003
P932PMC publication ID6741171
P698PubMed publication ID12832508

P2093author name stringNickolay Brustovetsky
Tatiana Brustovetsky
Martin Crompton
Michela Capano
Janet M Dubinsky
Kevin J Purl
P2860cites workA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingQ25938984
Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membraneQ28208002
The Ca2+-induced membrane transition in mitochondria. I. The protective mechanismsQ28305411
Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH : ubiquinone oxidoreductase) in rat brainQ28565020
Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerizationQ28568395
Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transitionQ28569445
Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?Q28590813
High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondriaQ28610852
The mitochondrial permeability transition pore and its role in cell deathQ29614183
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degenerationQ30992818
Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition poreQ31942254
Intracellular ATP, a switch in the decision between apoptosis and necrosis.Q33533984
Cyclophilins and their possible role in the stress responseQ33815808
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.Q34062645
Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlationsQ34081469
The mitochondrial potassium cycleQ34499054
Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adeniQ38340859
Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocaseQ38559578
The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolismQ38608271
Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme systemQ39072565
3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms.Q39449440
Role of ubiquinone in the mitochondrial generation of hydrogen peroxideQ40005741
The mitochondrial permeability transition.Q40462729
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.Q40721588
Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress.Q41308388
Mitochondrial heterogeneity in the brain at the cellular levelQ41719646
Mitochondrial channel activity studied by patch-clamping mitoplastsQ42014495
The reversible Ca2+-induced permeabilization of rat liver mitochondriaQ42067210
Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.Q42438521
Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stressQ42818406
Regulation of the mitochondrial matrix volume in vivo and in vitro. The role of calciumQ42853961
Liver mitochondrial pyrophosphate concentration is increased by Ca2+ and regulates the intramitochondrial volume and adenine nucleotide contentQ42856797
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.Q43662825
Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain.Q43664667
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseQ43669934
DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondriaQ43777368
Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondriaQ43830043
Modulation of cyclophilin gene expression by N-4-(hydroxyphenyl)retinamide: association with reactive oxygen species generation and apoptosisQ43864576
Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugationQ43950113
Effect of aging and acetyl-L-carnitine on energetic and cholinergic metabolism in rat brain regionsQ44190948
The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria.Q44810762
Effect of metal cations on the inhibition of adenine nucleotide translocation by acyl-CoAQ45173595
The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A.Q45215970
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's diseaseQ45298860
Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse modelQ45304699
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.Q45305438
Oxidative metabolism of nonsynaptic mitochondria isolated from rat brain hippocampus: a comparative regional studyQ48097336
Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerabilityQ48198160
Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat?Q48211276
Phenobarbital and 6-aminonicotinamide effect on cerebral enzymatic activities related to energy metabolism in different rat brain areasQ48253404
Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamideQ48363902
The effect of age on the activity of enzymes of peroxide metabolism in rat brainQ48369490
Calcium-induced activation of the mitochondrial permeability transition in hippocampal neuronsQ48386508
Mitochondria and neuronal glutamate excitotoxicityQ48406562
Beneficial effects of naftidrofuryl oxalate on brain regional energy metabolism after microsphere-induced cerebral embolismQ48518049
Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.Q48546984
Reduced activity of the pyruvate dehydrogenase complex but not cytochrome c oxidase is associated with neuronal loss in the striatum following short-term forebrain ischemiaQ48580834
Influence of intermittent hypoxia and pyrimidinic nucleosides on cerebral enzymatic activities related to energy transductionQ48637560
The activities of some energy-metabolising enzymes in nonsynaptic (free) and synaptic mitochondria derived from selected brain regionsQ48673801
Structural and functional aspects of the respiratory chain of synaptic and nonsynaptic mitochondria derived from selected brain regionsQ48765883
On the regulation of K+ uniport in intact mitochondria by adenine nucleotides and nucleotide analogs.Q50785794
Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?Q52123671
The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A.Q54060908
The presence of two classes of high-affinity cyclosporin A binding sites in mitochondria. Evidence that the minor component is involved in the opening of an inner-membrane Ca(2+)-dependent pore.Q54085821
Changes induced by aging and drug treatment on cerebral enzymatic antioxidant systemQ60722292
Prominence of direct entorhinal-CA1 pathway activation in sensorimotor and cognitive tasks revealed by 2-DG functional mapping in nonhuman primateQ62168601
Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady stateQ66944710
Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stressQ67493487
Regional changes in the cellular level of adenine nucleotides in ischemic rat brain subjected to single embolizationQ68393935
Temporal evolution of regional energy metabolism following focal cerebral ischemia in the ratQ68437185
Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondriaQ69070569
Involvement of the ADP/ATP carrier in calcium-induced perturbations of the mitochondrial inner membrane permeability: importance of the orientation of the nucleotide binding siteQ69837943
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondriaQ70080329
Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+Q71186017
Enzymatic profile of mitochondria isolated from selected brain regions of young adult and one-year-old ratsQ71214917
Regional energy balance in rat brain after transient forebrain ischemiaQ71689939
Evidence for the Involvement of a Membrane-Associated Cyclosporin-A-Binding Protein in the Ca2+-Activated Inner Membrane Pore of Heart MitochondriaQ71845731
Selective Inhibition of the Tricarboxylic Acid Cycle of GABAergic Neurons with 3‐Nitropropionic Acid In VivoQ71978455
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acidQ72098398
Influence of divalent cations on the reconstituted ADP, ATP exchangeQ72864621
Dual responses of CNS mitochondria to elevated calciumQ73338084
Proton selective substate of the mitochondrial permeability transition pore: regulation by the redox state of the electron transport chainQ77333095
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarizationQ95810356
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectmitochondrionQ39572
striatumQ1319792
P304page(s)4858-4867
P577publication date2003-06-15
P1433published inJournal of NeuroscienceQ1709864
P1476titleIncreased susceptibility of striatal mitochondria to calcium-induced permeability transition
P478volume23

Reverse relations

cites work (P2860)
Q33539988A mathematical model of mitochondrial swelling
Q30577415Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity
Q38700215Beyond muscles: The untapped potential of creatine
Q55514851Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease.
Q36019780Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.
Q35893954Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease
Q36935277Calcium-induced precipitate formation in brain mitochondria: composition, calcium capacity, and retention
Q37237452Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration
Q50088379Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease.
Q33862724Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes.
Q42788385Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters
Q37114413Cyclophilin D is expressed predominantly in mitochondria of gamma-aminobutyric acidergic interneurons
Q57021971Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria
Q39273647Development or disease: duality of the mitochondrial permeability transition pore
Q46255661Experimental autoimmune encephalomyelitis from a tissue energy perspective.
Q30450114Fluorescence response of human HER2+ cancer- and MCF-12F normal cells to 200MHz ultrasound microbeam stimulation: a preliminary study of membrane permeability variation
Q27684278High-resolution crystal structures of two crystal forms of human cyclophilin D in complex with PEG 400 molecules
Q35664881Impaired import: how huntingtin harms
Q36297458Increased Expression of Osteopontin in the Degenerating Striatum of Rats Treated with Mitochondrial Toxin 3-Nitropropionic Acid: A Light and Electron Microscopy Study
Q46191238Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy
Q41993741Isolation of mitochondria from the CNS.
Q28208193Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
Q64387394Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice
Q28394301Metabolism in HD: still a relevant mechanism?
Q64074984Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors
Q60949053Mitochondrial Metabolism in Major Neurological Diseases
Q48284335Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Q37747170Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration
Q38170006Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury
Q37672741Mitochondrial medicine for neurodegenerative diseases
Q35799121Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease
Q37427280Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
Q27023850Mitochondrial permeability transition pore is a potential drug target for neurodegeneration
Q57170869Mitochondrial permeability transition pore: a potential drug target for neurodegeneration
Q45307199Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
Q53588721Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Q39891449Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux
Q37308357Mutant huntingtin and mitochondrial dysfunction
Q35282959NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage.
Q91972707Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?
Q36571516Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration.
Q39035184Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington's disease
Q37237423Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction and calcineurin activation.
Q34556735Protective effect of metformin on gentamicin-induced vestibulotoxicity in rat primary cell culture.
Q35891839Protective roles of CNS mitochondria
Q42019992Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death
Q37557789Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease
Q36597920Selective neuronal degeneration in Huntington's disease
Q41967848The challenge in translating basic research discoveries to treatment of Huntington disease
Q28072937The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease
Q36476846The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury
Q37765841The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease
Q35219902The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions
Q33664175Unlocking the Door to Neuronal Woes in Alzheimer's Disease: Aβ and Mitochondrial Permeability Transition Pore
Q93140140Voluntary exercise normalizes the proteomic landscape in muscle and brain and improves the phenotype of progeroid mice

Search more.